Compoundeer Logo
COMPOUNDEER
Uncovering Potential
RankingCompaniesDCF
CTKB Logo

Cytek Biosciences, Inc.

CTKB

Laboratory Analytical Instruments

Mkt Cap

$1.122B

PE

-80.55

Debt

$1.736M

Cash

$163.6M

EV

$960.4M

FCF

-$7.716M

Market Cap

$1.122B

P/E Ratio

-80.55

Debt

$1.736M

Cash

$163.6M

EV

$960.4M

FCF

-$7.716M
Charts data: {"Earnings":[{"time":"2020-12-30","value":3216000},{"time":"2021-12-30","value":0},{"time":"2022-12-30","value":2484000}],"Sales":[{"time":"2020-12-30","value":92839000},{"time":"2021-12-30","value":127950000},{"time":"2022-12-30","value":164036000}],"Net Margins":[{"time":"2020-12-30","value":0.03464061439696679},{"time":"2021-12-30","value":0},{"time":"2022-12-30","value":0.01514301738642737}],"Assets":[{"time":"2020-12-30","value":219979000},{"time":"2021-12-30","value":463305000},{"time":"2022-12-30","value":519476000}],"Stockholders Equity":[{"time":"2020-12-30","value":-16028000},{"time":"2021-12-30","value":405385000},{"time":"2022-12-30","value":425546000}],"ROE":[{"time":"2020-12-30","value":-0.2006488644871475},{"time":"2021-12-30","value":0},{"time":"2022-12-30","value":0.005837206788455302}],"ROA":[{"time":"2020-12-30","value":0.06559717063901555},{"time":"2021-12-30","value":0.01976451797412072},{"time":"2022-12-30","value":0.0024255211020335877}]}

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Sector

  • A Logo

    A

  • AVTR Logo

    AVTR

  • BIO Logo

    BIO

  • BRKR Logo

    BRKR

  • EYPT Logo

    EYPT

  • ILMN Logo

    ILMN

  • MTD Logo

    MTD

  • NAUT Logo

    NAUT

  • PACB Logo

    PACB

  • QTRX Logo

    QTRX

In the chart Earnings are multiplied by this value.

Earnings Growth -2.5%
Earnings Stability -120%


Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12-202012-202112-2022TTM
Net Margin3.5%0%1.5%-7.6%
ROA6.6%2%0.24%-3.2%
ROE-20%0%0.58%-3.4%

What is the average Net Margin?

The average Net Margin over the past 5 years is +1.66%.

What is the trend of Net Margin?

The trend of Net Margin over the past 5 years is -0.97%.

What is the average Return on Assets (ROA)?

The average ROA over the past 5 years is +2.93%.

What is the trend of Return on Assets (ROA)?

The trend of ROA over the past 5 years is -3.16%.

What is the average Return on Equity (ROE)?

The average ROE over the past 5 years is -6.49%.

What is the trend of Return on Equity (ROE)?

The trend of ROE over the past 5 years is +10.32%.


Safety & Stabiliy

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12-202012-202112-2022TTM
Debt FCF-0.00-0.10-0.22
Debt Equity-0.000.010.00
MIN
Graham Stability----

What is the Debt/FCF?

The Debt/FCF trailing twelve month is -0.22.

What is the trend of Debt/FCF?

The trend of Debt/FCF over the past 5 years is -0.10.

What is the Graham’s Stability?

Graham’s Stability measure stands at -.


Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12-2021Trend
Revenue28%-9.6%
Net Income--
Stockholders Equity5%-
FCF--

What is the 5 year Revenue CAGR?

The Revenue CAGR over the past 5 years is -.

What is the trend of Revenue growth?

The trend of Revenue growth rate over the past 5 years is -9.62%.

What is the 5 year Earnings CAGR?

The Earnings CAGR over the past 5 years is -.

What is the trend of Earnings growth?

The trend of Earnings growth rate over the past 5 years is -.

What is the 5 year Equity CAGR?

The Equity CAGR over the past 5 years is -.

What is the trend of Equity growth?

The trend of Equity growth rate over the past 5 years is -.

What is the 5 year FCF CAGR?

The FCF CAGR over the past 5 years is -.

What is the trend of FCF growth?

The trend of FCF growth rate over the past 5 years is -.